ACADIA Pharmaceuticals Inc. (ACAD)

Last Closing Price: 22.90 (2025-11-20)

Net Income (Quarterly)

Net Income: Company's net profit or loss after all revenues, income items, and expenses have been accounted for. Because this figure is given after preferred dividend expense, it is the net income value allotted to common shareholders.

ACADIA Pharmaceuticals Inc. (ACAD) had Net Income of $71.78M for the most recently reported fiscal quarter, ending 2025-09-30.

Figures for fiscal quarter ending 2025-09-30
Income Statement Financials
$278.63M
Net Income
$71.78M
$21.65M
$256.99M
$242.88M
$35.76M
$8.84M
$44.59M
$44.59M
$71.78M
$71.78M
$71.78M
$71.78M
$35.76M
$37.60M
168.84M
170.65M
$0.43
$0.42
Balance Sheet Financials
$1.08B
$3.71M
$254.35M
$1.33B
$356.58M
--
$56.91M
$413.50M
$917.27M
$805.66M
$917.27M
169.15M
Cash Flow Statement Financials
$158.57M
$-246.69M
$27.22M
$328.36M
$267.47M
$-60.89M
$38.90M
--
--
Fundamental Metrics & Ratios
3.02
--
--
--
--
92.23%
12.83%
12.83%
--
16.00%
25.76%
$157.88M
--
--
--
0.21
0.74
2.00
45.04
7.83%
8.91%
5.39%
7.83%
$5.42
$0.93
$0.93